Endo 2 SLO Practice (online) Page 1 of 7

Similar documents
Endocrine Pharmacology:

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

I. General Considerations

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Oral and Injectable Medication Options for Diabetes Treatment

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

Endocrine. Hormones secreted from glands. Gonads

RPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Table 1. Antihyperglycemic agents for use in type 2 diabetes

DM Fundamentals Class 4 Meds for Type 2

Metformin Hydrochloride

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

Oral and Injectable Non-insulin Antihyperglycemic Agents

Xultophy 100/3.6. (insulin degludec, liraglutide) New Product Slideshow

DM Fundamentals Class 4 Meds for Type 2

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),

Wayne Gravois, MD August 6, 2017

Diabetes Management: A diagnostic perspective

Drugs used in Diabetes. Dr Andrew Smith

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013

Diabetes Mellitus II CPG

What s New in Diabetes Treatment. Disclosures

The Community Pharmacist s Role in Diabetes Treatment

Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical

Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018

Diabetes Medications: Oral Anti-Hyperglycemic Medications

Oral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action

Newer and Expensive treatment of diabetes. Endocrinology Visiting Associate Professor Institute of Medicine TUTH

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Type II Diabetes Improving Blood Sugar Control. Geneva Clark Briggs, Pharm.D., BCPS

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function

INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University

4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis

Pancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4)

Glucose Control drug treatments

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

What s New in Diabetes Medications. Jena Torpin, PharmD

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care

How to Fight Diabetes and Win. Diabetes. Medications

What is Diabetes Mellitus?

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Antidiabetic Agents CHAPTER BIGUANIDES

AACE/ACE Consensus Statement American Association of Clinical Endocrinologists and American College of Endocrinology

Newer Drugs in the Management of Type 2 Diabetes Mellitus

3/8/2011. Julie M. Sease, Pharm D, BCPS, CDE Associate Professor of Pharmacy Practice Presbyterian College School of Pharmacy

History of Investigation

The Many Faces of T2DM in Long-term Care Facilities

Pancreatic b-cell Dysfunction in Type 2 Diabetes ZIAD KAHWASH, M.D. Insulin resistance: Defects in Insulin Signaling

Quick Guide MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes.

第十五章. Diabetes Mellitus

Treatment Options for Diabetes: An Update

Soliqua 100/33. (insulin glargine, lixisenatide) New Product Slideshow

Endocrine System. Regulating Blood Sugar. Thursday, December 14, 17

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix

Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Therapy of Diabetes Mellitus

Pharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)

Non-Insulin Diabetes Medications Summary

Rhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain

Glyceamic control is indicated by 1. Fasting blood sugar less than 126 mg/dl 2. Random blood sugar 3. HbA1c less than 6.5 % Good glycaemic control

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

New Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum

Diabetes in Pregnancy

Update on Diabetes Mellitus

DIABETES RESEARCH A CLINICIAN S OVERVIEW

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Choosing a Diabetes Strategy Where to Start and Where to Go

Diabetes Mellitus Type 2

Diabetes School October 2016

Initiating Injectable Therapy in Type 2 Diabetes

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville

TREATMENT OF DIABETES AFTER METFORMIN GREGG GERETY, MD ALBANY MEDICAL COLLEGE, DIVISION OF COMMUNITY ENDOCRINOLOGY JULY 14, 2017

Comprehensive Diabetes Treatment

Diabetes, Drugs and Dangerous Discrepancies. Sally Bodenhamer, OD, OT/L, CDE

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate

FUNDING: MICIS mandated by Maine Legislature, funded by fees collected from pharmaceutical companies as a cost of doing business in the state.

Blood Glucose Monitoring

associated with serious complications, but reduce occurrences with preventive measures

Clinical Practice Guidelines

6/1/2018. Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE

Disclosure. Learning Objectives. Case. Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare

Type 2 Diabetes Mellitus 2011

What s New on the Horizon: Diabetes Medication Update

Julie White, MS Administrative Director Boston University School of Medicine Continuing Medical Education

2018 Diabetes Summit Managing Diabetes: An Art and a Science

Care of patients with endocrine system disorders

What s New on the Horizon: Diabetes Medication Update. Michael Shannon, MD Providence Endocrinology, Olympia WA

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy

Type. Diabetes Drugs. A Review

Transcription:

Endo 2 SLO Practice (online) Page 1 of 7 1. A long- acting insulin, like Lantus is for? A. When the next meal is within 30-60 minutes of the injection B. Over night use or for ½ of the day often combined with another form C. Taking with meals, often combined with longer acting form. D. Covering the whole day (24 hrs.), providing "basal" insulin and may be combined with another form 2. A major consequence of insulin binding to its cell surface receptors on muscle and fat cells is the translocation of the GLUT- 4 transporter from the cytosol to the cell surface, allowing? to flow into the cell. A. Cholesterol B. Glycogen C. Calcium D. Glucose E. Fatty acids 3. A number of drugs increase the risk of severe hypoglycemia when given with sulfonylureas. Which of the following should be avoided or used with great caution by patients taking a sulfonylurea? A. NSAIDs and salicylates in large doses B. Sulfonamides including thiazide diuretics C. Coumarins (e.g., warfarin) D. Beta blockers E. All the above 4. A Rapid- acting insulin, like Humalog is for A. When the next meal is within 30-60 minutes of the injection B. Covering the whole day (24 hrs.) and may be combined with another form C. Taking with meals, often combined with longer acting form. D. Over night use or for ½ of the day often combined with another form 5. A short- acting insulin, like Humulin is for? A. Taking with meals, often combined with longer acting form. B. Over night use or for ½ of the day often combined with another form C. Covering the whole day (24 hrs.) and may be combined with another form D. When the next meal is within 30-60 minutes of the injection 6. A type of diabetes that has mixed DMT1 & DMT2 characteristics is associated with A. Diabetes mellitus type 1 B. Diabetes mellitus type 2 C. Cystic fibrosis D. Diabetes insipidus E. Gestational diabetes 7. Acarbose (Precose) inhibits a glucosidase, which means it acts to reduce blood glucose by? A. Blocking hepatic gluconeogenesis B. Preventing the digestion and absorption of carbohydrates C. Stimulating the pancreas to release more insulin D. Mimicking incretins E. Preventing the breakdown of incretins

Endo 2 SLO Practice (online) Page 2 of 7 8. Acarbose (Precose) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. Parenteral /DMT1 B. Oral /DMT 1 and DMT 2 C. Parenteral/Hypoglycemia D. Parenteral /DMT1 and some cases of DMT2 E. Oral /Diabetes insipidus 9. Alpha glucosidase inhibitors like? are associated with gas. A. Glucagon B. Acarbose C. Metformin D. Insulin E. Liraglutide 10. An Intermediate- acting insulin, like NPH is for? A. Over night use or for ½ of the day often combined with another form B. Taking with meals, often combined with longer acting form. C. When the next meal is within 30-60 minutes of the injection D. Covering the whole day (24 hrs.) & may be combined with another form 11. Bromocriptine given in very low doses first thing in the morning is indicated to help provide glycemic control in DMT2 patients along with diet and exercise. This product is called? A. Cycloset B. Parlodel C. Navane D. Stalevo E. L- Dopa 12. Chlorpropamide (Diabinese) is a 1 st generation sulfonylurea, which makes it a secretagogue. What does secretagogue mean? A. It stimulates the pancreas to secrete glucagon B. It causes muscle and fat cells to secrete insulin C. It stimulates the pancreas to secrete insulin D. It prevents the pancreas from releasing insulin E. It inhibits secreted insulin from binding to its receptor 13. Chlorpropamide (Diabinese) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. None of the given answers is correct B. Oral /DMT2 C. Oral /DMT1 D. Oral /Diabetes insipidus E. Parenteral /DMT1 and some cases of DMT2 14. Exogenous? is associated with the release of catecholamines. A. DDP4 inhibitors B. Glucagon C. Acarbose D. Insulin E. GLP- 1 agonists

Endo 2 SLO Practice (online) Page 3 of 7 15. Glucagon (Glucagen) is a(n)? drug used to treat A. Oral /DMT1 B. Oral/DMT2 C. Parenteral/Hyperglycemia D. Parenteral/Hypoglycemia E. Parenteral/Diabetes insipidus 16. Glucagon (Glucagen) replaces a naturally occurring hormone that acts to? A. Increase insulin sensitivity B. Reduce blood glucose levels C. Elevate blood glucose levels D. Increase glucose uptake by muscle and fat cells E. Stimulate fatty acid synthesis 17. Glyburide (Micronase) is a 2 nd generation sulfonylurea which means you must have a functioning A. Pancreas B. Gall bladder C. Kidney D. Liver E. Lung 18. Glyburide (Micronase) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. Oral /Diabetes insipidus B. Oral /DMT2 C. Parenteral /DMT1 and some cases of DMT2 D. Oral /DMT1 E. Oral/any form of diabetes 19. Insulin and glucagon are given? to avoid total losses due to 1 st pass: A. Rectally B. Sublingually C. Parenterally D. Topically E. Transdermally 20. Insulin may cause? A. Cancer B. Hyperglycemia C. Lactic acidosis D. Pancreatitis E. Hypoglycemia 21. Lactic acidosis may be fatal in patients with poor renal function taking A. DDP4 inhibitors B. Metformin C. Sulfonylureas D. Insulin E. GLP- 1 agonists

Endo 2 SLO Practice (online) Page 4 of 7 22. Liraglutide (Victoza) acts by? A. Blocking hepatic gluconeogenesis B. Mimicking incretins C. Stimulating the pancreas to release more insulin D. Preventing the breakdown of incretins E. Preventing the digestion and absorption of carbohydrates 23. Liraglutide (Victoza) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. Oral /Diabetes insipidus B. Parenteral /DMT2 C. Parenteral/Diabetes insipidus D. Oral /DMT2 E. Oral /DMT1 24. Liraglutide, a?, may be associated with thyroid cancer. A. Metformin B. Sulfonylureas C. DDP4 inhibitors D. GLP- 1 agonists E. Human insulin 25. Metformin (Glucophage) is a nonsulfonylurea with a unique mechanism. It is believed to work by: A. Inhibiting an enzyme that breaks down incretins B. Preventing the digestion and absorption of carbohydrates C. Stimulating the pancreas to release insulin D. Mimicking incretins E. Blocking hepatic gluconeogenesis 26. Patients with pre- existing congestive heart failure have a higher risk of death if taking These drugs are also associated with weight gain, edema and hypoglycemia. A. Sulfonylureas B. Insulin C. GLP- 1 agonists D. PPAR gamma agonists E. Metformin 27. Pioglitazone (Actos) is a PPAR agonist used in combo with insulin or sulfonylurea to treat DMT2. It acts to? by triggering synthesis of factors involved in glucose and lipid metabolism. A. Cause insulin resistance B. It has no effect on insulin resistance C. Increase insulin resistance D. Decrease insulin resistance E. Eliminate insulin resistance 28. Pioglitazone (Actos) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat? A. Oral /DMT1 B. Parenteral/hypoglycemia C. Oral /DMT2 D. Parenteral /DMT1 and some cases of DMT2 E. Oral /Diabetes insipidus

Endo 2 SLO Practice (online) Page 5 of 7 29. Sitagliptin (Januvia) is a DPP4 inhibitor that acts to? A. Prevent the digestion and absorption of carbohydrates B. Block hepatic gluconeogenesis C. Stimulate the pancreas to release more insulin D. Prevent the breakdown of incretins E. Mimic incretins 30. Sitagliptin (Januvia) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. Parenteral/ Hypoglycemia B. Parenteral /DMT1 and some cases of DMT2 C. Oral /DMT2 D. Oral /DMT1 E. Oral /Diabetes insipidus 31. The blood glucose lowering effects of Metformin are antagonized by A. Isoniazid or INH B. Corticosteroids, including glucocorticoids like prednisone C. Estrogens, including birth control pills D. Thiazide diuretics E. All the listed answers are correct 32. The normal effect of insulin binding is that blood glucose A. Plummets, leading to hypoglycemia B. Is maintained at one level C. Goes down D. Insulin has none of these effects E. Rises, leading to hyperglycemia 33. The severe side effects of weight gain, severe hypoglycemia and increased risk of cardiovascular death including heart attack are associated with A. GLP- 1 agonists B. Insulin C. DDP4 inhibitors D. Sulfonylureas E. Metformin 34. The type of diabetes associated with a lack of ADH is called A. Gestational diabetes B. Diabetes insipidus C. Diabetes mellitus type 2 D. Diabetes mellitus type 1 E. Cystic fibrosis diabetes 35. The type of diabetes commonly called Adult onset is related to insulin resistance and is also called A. Diabetes mellitus type 2 B. Cystic fibrosis diabetes C. Gestational diabetes D. Diabetes mellitus type 1 E. Diabetes insipidus

Endo 2 SLO Practice (online) Page 6 of 7 36. The type of diabetes known as Juvenile onset is related to a failure of the pancreas to produce insulin and is also known as A. Diabetes mellitus type 1 B. Diabetes mellitus type 2 C. Diabetes insipidus D. Cystic fibrosis diabetes E. Gestational diabetes 37. Type of diabetes associated with pregnancy is called? A. Diabetes insipidus B. Diabetes mellitus type 1 C. Diabetes mellitus type 2 D. Cystic fibrosis diabetes E. Gestational diabetes 38. Which drug requires a functioning pancreas and so cannot be used in DMT1? A. Acarbose (Precose) B. Neutral Protamine Hagedorn insulin C. Regular (Humulin) insulin D. Metformin (Glucophage) E. Glyburide (Micronase) 39. Which drug requires functional kidneys to minimize the risk of lactic acidosis? A. Glyburide B. Metformin C. Insulin Lispro D. Chlorpropamide E. Insulin Aspart 40. Which drug requires insulin to be present, so requires either a functioning pancreas or is given as an adjunct to insulin? A. Pioglitazone (Actos) B. Liraglutide (Victoza) C. Glucagon (Glucagen) D. Insulin Lispro E. Sitagliptin (Januvia) 41. Which of the following are symptoms of HYPERglycemia? A. Lethargy, pin point pupils and respiratory depression B. Sweating, tremors and hunger C. Constipation, dry skin, tremors, dilated pupils D. Dry skin, dry mouth and thirst E. SJS, hypokalemia, kidney failure 42. Which of the following are symptoms of HYPOglycemia? A. Constipation, dry skin, tremors, dilated pupils B. Dry skin, dry mouth and thirst C. Lethargy, pin point pupils and respiratory depression D. SJS, hypokalemia, kidney failure E. Sweating, tremors and hunger

Endo 2 SLO Practice (online) Page 7 of 7 43. Insulin is used to treat A. Only DMT1, never DMT2 B. All forms of diabetes C. Diabetes insipidus only D. Only DMT2, never DMT1 E. DMT1 and some cases of DMT2 44. Metformin (Glucophage) is a(n)? antihyperglycemic drug indicated as an adjunct to diet and exercise to treat A. Oral /DMT2 B. Parenteral /DMT1 and some cases of DMT2 C. Oral /DMT1 D. Oral /Diabetes insipidus E. Parenteral/any form of diabetes